Brincidofovir for the treatment of human adenovirus infection in pediatric solid organ transplant recipients : A case series
© 2020 Wiley Periodicals LLC..
HAdV viremia can cause significant morbidity among pediatric recipients of SOT with variability in incidence and severity of disease based on the type of allograft. Currently, there are no US FDA-approved treatments for HAdV infections, and historically, the mainstay of treatment has been decreasing immunosuppression, with antiviral therapies reserved for those with severe disease. We describe the treatment of four pediatric SOT recipients (two kidney, one combined kidney-liver, and one liver) presenting with HAdV disease at our institution using brincidofovir. Our case series highlights the variability in presentation and the potential for severe disease in pediatric SOT recipients as we review disease presentation, disease course, complications, and treatment with brincidofovir.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
Pediatric transplantation - 24(2020), 7 vom: 21. Nov., Seite e13769 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Londeree, Jackson [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
6794O900AX |
|---|
| Anmerkungen: |
Date Completed 07.10.2021 Date Revised 07.10.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/petr.13769 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM311368158 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311368158 | ||
| 003 | DE-627 | ||
| 005 | 20231225142113.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/petr.13769 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1037.xml |
| 035 | |a (DE-627)NLM311368158 | ||
| 035 | |a (NLM)32558134 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Londeree, Jackson |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Brincidofovir for the treatment of human adenovirus infection in pediatric solid organ transplant recipients |b A case series |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.10.2021 | ||
| 500 | |a Date Revised 07.10.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 Wiley Periodicals LLC. | ||
| 520 | |a HAdV viremia can cause significant morbidity among pediatric recipients of SOT with variability in incidence and severity of disease based on the type of allograft. Currently, there are no US FDA-approved treatments for HAdV infections, and historically, the mainstay of treatment has been decreasing immunosuppression, with antiviral therapies reserved for those with severe disease. We describe the treatment of four pediatric SOT recipients (two kidney, one combined kidney-liver, and one liver) presenting with HAdV disease at our institution using brincidofovir. Our case series highlights the variability in presentation and the potential for severe disease in pediatric SOT recipients as we review disease presentation, disease course, complications, and treatment with brincidofovir | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a brincidofovir | |
| 650 | 4 | |a case report | |
| 650 | 4 | |a human adenovirus | |
| 650 | 4 | |a pediatrics | |
| 650 | 4 | |a solid organ transplantation | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a Organophosphonates |2 NLM | |
| 650 | 7 | |a brincidofovir |2 NLM | |
| 650 | 7 | |a 6794O900AX |2 NLM | |
| 650 | 7 | |a Cytosine |2 NLM | |
| 650 | 7 | |a 8J337D1HZY |2 NLM | |
| 700 | 1 | |a Winterberg, Pamela D |e verfasserin |4 aut | |
| 700 | 1 | |a Garro, Rouba |e verfasserin |4 aut | |
| 700 | 1 | |a George, Roshan P |e verfasserin |4 aut | |
| 700 | 1 | |a Shin, Stella |e verfasserin |4 aut | |
| 700 | 1 | |a Liverman, Rochelle |e verfasserin |4 aut | |
| 700 | 1 | |a Serluco, Anastacia |e verfasserin |4 aut | |
| 700 | 1 | |a Romero, Rene |e verfasserin |4 aut | |
| 700 | 1 | |a Yildirim, Inci |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pediatric transplantation |d 1997 |g 24(2020), 7 vom: 21. Nov., Seite e13769 |w (DE-627)NLM097406473 |x 1399-3046 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2020 |g number:7 |g day:21 |g month:11 |g pages:e13769 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/petr.13769 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2020 |e 7 |b 21 |c 11 |h e13769 | ||